Table 5.
Skin preparation agent | |||||
---|---|---|---|---|---|
Characteristic | CHG (n = 141) | CHG+IPA (n = 323) | PVI (n = 87) | IPC+IPA (n = 47) | p Value |
Age, y, mean (±SD) | 64.9 (14.8) | 63.9 (16.3) | 63.6 (15.4) | 66.9 (14.2) | 0.41 |
Male, % | 47.5 | 50.2 | 44.8 | 44.4 | 0.08 |
Comorbidity Index, % | 0.02 | ||||
0 | 61.0 | 60.1 | 67.8 | 57.8 | |
1 | 22.0 | 27.2 | 20.7 | 35.6 | |
2 | 12.8 | 8.4 | 5.8 | 4.4 | |
3+ | 4.3 | 4.3 | 5.8 | 2.2 | |
ASA Class, % | 0.24 | ||||
I | 2.9 | 2.9 | 0 | 0 | |
II | 33.6 | 32.4 | 43.0 | 24.4 | |
III | 55.7 | 54.2 | 50.0 | 68.9 | |
IV+ | 7.8 | 11.2 | 7.0 | 6.7 | |
BMI, kg/m2, mean (SD) | 28.1 (7.0) | 28.4 (6.8) | 26.6 (5.7) | 28.2 (6.9) | 0.15 |
Current smoker, % | 19.1 | 23.9 | 25.3 | 26.7 | 0.04 |
Serum albumin <3, % | 39.0 | 21.4 | 33.3 | 28.9 | 0.01 |
Current steroid use, % | 7.1 | 3.7 | 6.9 | 8.9 | 0.26 |
Surgical approach, % | 0.43 | ||||
Laparoscopic | 7.8 | 7.5 | 4.6 | 2.2 | |
Laparoscopic/converted | 6.4 | 5.9 | 1.2 | 4.4 | |
Laparoscopic/hand | 10.6 | 8.0 | 5.8 | 15.6 | |
Open | 73.1 | 75.8 | 88.5 | 77.8 | |
Laparoscopic robotic | 1.4 | 1.9 | 0 | 0 | |
Laparoscopic robotic converted | 0.7 | 0.9 | 0 | 0 | |
Bowel prep used, % | 49.1 | 48.9 | 54.7 | 42.2 | 0.27 |
Perioperative hyperglycemia, % | 80.1 | 80.2 | 77.0 | 84.4 | 0.79 |
Perioperative hypothermia, % | 8.5 | 8.7 | 5.8 | 2.2 | 0.41 |
Procedure duration, min, mean (SD) | 165.0 (91.5) | 193.0 (110.5) | 158.6 (106.5) | 145.8 (69.6) | 0.03 |
Length of stay, d, mean (SD) | 16.4 (8.2) | 16.4 (8.5) | 16.8 (10.6) | 16.6 (8.5) | 0.82 |
CHG, chlorhexidine; CHG+IPA, chlorhexidine in isopropyl alcohol; PVI, povidone-iodine; IPC+IPA, povacrylx-iodine in isopropyl alcohol; IPA, isopropyl alcohol.